Atlas Trials

FOLFOX/FOLFIRI Containing Levofolinic Acid (Zuoyu ®) in the Treatment of Unresectable or Metastatic Colorectal Cancer

Clinical trial NCT05797883 · UNKNOWN

Trial details

NCT number
NCT05797883
Sponsor
China Medical University, China
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Unresectable or Metastatic Colorectal Cancer
Start date
2022-08-01
Primary completion
2023-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.